Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma

doi:10.3748/wjg.14.1274

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3018)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

301

HTML

2478

Figures (1-5)

239

Sum=3018

Feb 28, 2008 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 28, 2008; 14(8): 1274-1279
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1274

Full Size Figure Download Figure

Figure 3 Proliferation selectivity of CNHK300-GFP in Hep3B (upper) and BJ (lower) under fluorescence microscope. CNHK300-GFP could infect both BJ cells and Hep3B cells. But after days of infection, CNHK300-GFP virus could proliferate effectively in cancer cells and induced cytopathologic effect (CPE) at d 7, whereas in normal cell lines, CNHK300-GFP proliferation was attenuated, and BJ cells did not show CPE after days of infection.

Citation: Li YM, Song ST, Jiang ZF, Zhang Q, Su CQ, Liao GQ, Qu YM, Xie GQ, Li MY, Ge FJ, Qian QJ. Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma. World J Gastroenterol 2008; 14(8): 1274-1279
URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1274.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1274